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MAF_AA	=	0.1,	 FMO6P).	 No	 significant	 signals	 were	 identified	 through	 haplotype-	
based	 analyses.	 Gene	 network	 investigation	 indicated	 that	 both	 FMO1	 and	 FMO3 
have	a	strong	relation	with	a	variety	of	genes	belonging	to	CYP	gene	families	 (with	














(WHO,	 2013).	 Strong	 evidence	 connects	 cigarette	 smoking	 and	 lung	
cancer	 (Biesalski	 et	al.,	 1998;	Doll	&	Hill,	 1954;	Doll,	 Peto,	Boreham,	
&	 Sutherland,	 2004;	 Hecht,	 2012),	 and	 according	 to	 the	 data	 from	
American	cancer	society,	lung	cancer	causes	the	most	death	each	year	
compared	 to	 other	 cancers	 (Shafey,	 Eriksen,	 Ross,	 &	Mackay,	 2009).	
In	addition,	cigarette	smoking	 is	also	 the	principal	environmental	 risk	
factor	 for	 developing	 chronic	 obstructive	 pulmonary	 disease,	 a	 dis-
ease	 characterized	 by	 chronically	 poor	 airflow	 (Kennedy,	 Chambers,	




Early	 studies	 based	 on	 samples	 of	 twins	 have	 linked	 the	 life-





studies	have	 identified	several	 susceptible	 loci,	 including	genes	en-
coding	dopamine	transporter/receptors	(Huang	et	al.,	2008;	Lerman	
et	al.,	 1999;	 Sabol	 et	al.,	 1999),	 cholinergic	 receptors	 (Feng	 et	al.,	
2004;	 Hong	 et	al.,	 2010;	 Saccone	 et	al.,	 2006;	 Thorgeirsson	 et	al.,	
2010),	taste	receptor	(Mangold,	Payne,	Ma,	Chen,	&	Li,	2008),	sero-
tonin	receptor	(Gerra	et	al.,	2005;	Kremer	et	al.,	2005),	and	gamma-	
aminobutyric	 acid	 type	 B	 receptor	 (Beuten	 et	al.,	 2005),	 that	 are	
associated	with	nicotine	dependence.	The	breakthrough	of	microar-





Thorgeirsson	 et	al.,	 2008;	Uhl	 et	al.,	 2007),	 and	 greatly	 accelerates	
the	 progress	 of	 this	 gene	 hunting	 process.	 Nevertheless,	 GWAS	
only	 focuses	on	a	 set	of	preselected,	 generally	 common	SNPs,	 and	
tends	to	omit	the	rare	variants	and	structural	variants	such	as	short	








Three	protein	 families	 are	 involved	 in	nicotine	pharmacokinetics:	





















risk	 of	 nicotine	 dependence	via	 deep	 targeted	 sequencing	 in	 2,820	




aimed	 to	 investigate	 the	potential	 association	between	FMO	genes	
and	 nicotine	 dependence.	 Via	 implementing	 targeted	 sequencing,	
we	are	interested	to	figure	out	that	whether	rare	variants	contribute	
to	the	association	signal	derived	from	common	variants.	 In	addition,	











African	 Americans	 were	 examined	 in	 our	 study.	 We	 assessed	 the	
K E Y W O R D S
flavin-containing	monooxygenase,	genetic	association,	rare	variants,	targeted	sequencing
     |  3 of 8ZHANG et Al.
study	subjects’	smoking	behavior	using	Fagerström	test	for	nicotine	
dependence	 (FTND;	Heatherton,	Kozlowski,	Frecker,	&	Fagerström,	




2.2 | Targeted sequencing of FMO1 and FMO3
DNA	 samples	 were	 extracted	 from	 blood	with	 Puragene.	 Targeted	
sequencings	on	 two	100	kb	 regions	of	FMO1	 and	FMO3	were	per-
formed	at	the	Center	for	Inherited	Disease	Research.	These	genomic	







A	 total	 of	1,432	European	Americans	 and	1,388	African	Americans	
with	 targeted	 sequencing	 of	 FMO1	 and	 FMO3	 were	 examined.	
General	 data	 analyses	 were	 performed	 by	 R	 (R	 i386	 3.2.1;	 Ripley,	
2001).	 To	 quantify	 the	 potential	 population	 stratification,	 we	 con-
ducted	principal	 component	 analysis	 (PCA)	 in	 the	 combined	 sample	
(115,338	markers),	 as	well	 as	 separately	 in	 the	 European	American	
sample	 (154,049	 markers)	 and	 African	 American	 sample	 (218,399	
markers),	using	a	previous	collected	genome-	wide	array	dataset	con-






criteria	 used	 can	 be	 found	 in	 supplemental	methods.	 After	 variant-	
level	quality	control,	5,105,	2,600,	and	3,817	variants	located	within	
the	 two	 targeted	 genomic	 regions	 (FMO1/FMO3)	 were	 extracted	













American	 and	African	American	 subjects).	Gender	 and	 age	were	 in-
cluded	as	covariates	 in	all	the	three	analyses.	The	first	two	principal	
components	based	on	the	three	sample	sets	were	also	utilized	as	co-










algorithm	 taken	 from	Gabriel	 et	al.	 (2002).	 On	D′,	 95%	 confidence	
bounds	 are	 generated	 and	 each	 comparison	 is	 called	 “strong	 LD”	
when	 the	 confidence	 bounds	 have	 upper	 bound	 ≥0.98	 and	 lower	
bound	≥0.7,	and	a	block	is	created	if	95%	of	informative	comparisons	
are	 “strong	 LD.”	Variant-	level	 association	 analysis	 and	 LD	 construc-
tion	and	haplotype	analyses	were	conducted	using	Plink	(Purcell	et	al.,	
2007).	 Bonferroni	 correction	 was	 also	 applied	 to	 haplotype-	based	
analyses.	 Six	 haplotypes	were	 constructed	 and	 tested	 in	 European	






variants	 set	 (i.e.,	 the	 variants	 located	 within	 the	 gene	 region)	 and	 
(2)	functional-	region	variants	(variants	located	within	regions	with	sig-
nificant	 functional	 significance,	 including	exonic	 regions,	 3′/5′	UTR,	
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2.4 | Bioinformatics analysis
We	examined	 the	 targeted	 SNPs	 and/or	 genes	 using	 several	 bioin-
formatics	 tools	 and	 databases.	We	 utilized	 the	 protein–protein	 in-













sample	 set,	 respectively.	 LD	 blocks	 were	 constructed	 in	 European	
American	and	African	American	sample	sets	(Tables	S2	and	S3).	Based	
on	 these	 LD	 blocks	 patterns,	 the	 significant	 thresholds	 for	 variant-	
wise	analysis	were	3.6	×	10−3	and	1.25	×	10−3	in	European	American	
and	African	American	 sample	 set,	 respectively.	We	chose	 the	most	
conservative	one	as	our	p-	value	threshold	in	the	analysis	(1.25	×	10−3).	








3.2 | Haplotype- based and gene- wise association of 
FMO genes and nicotine dependence
We	performed	haplotype-	based	analyses	in	European	American	and	
African	 American	 dataset	 separately.	 The	 p-	value	 thresholds	 were	
TABLE  2 Significant	signals	in	variant-	wise	association	analysis
CHR VAR GENE POS A1 OR_EA p_EA MAF_EA OR_AA p_AA MAF_AA
1 rs11812044 FMO6P 171115567 A 1.16 .1232 0.19 0.65 .0012 0.10
1 rs17565793 FMO6P 171116267 C 1.16 .1232 0.19 0.65 .0012 0.10
1 rs17623477 FMO6P 171116304 C 1.16 .1232 0.19 0.65 .0012 0.10
1 rs7051747 FMO6P 171116550 G 1.16 .1232 0.19 0.65 .0012 0.10
1 rs7066454 FMO6P 171116603 T 1.16 .1232 0.19 0.65 .0012 0.10
1 rs7063044 FMO6P 171116760 T 1.16 .1232 0.19 0.65 .0012 0.10
1 rs6608453 FMO6P 171117140 T 1.17 .1109 0.19 0.64 .0010 0.10
1 rs6608454 FMO6P 171117170 C 1.16 .1232 0.19 0.65 .0012 0.10
1 rs12726624 FMO1 171231630 G 0.67 .0004 0.13 1.03 .7385 0.47
1 rs17581251 FMO1 171232446 T 0.67 .0011 0.12 0.98 .8685 0.08
1 rs28360379_indel FMO1 171234851 A 0.68 .0006 0.13 0.99 .8698 0.43
1 rs6674596 FMO1 171235088 T 0.67 .0004 0.14 1.01 .9325 0.46
1 rs13376631 FMO1 171235742 G 0.69 .0009 0.13 1.00 .9831 0.43
1 rs12094878 FMO1 171243863 C 0.69 .0012 0.14 1.04 .6315 0.47
1 rs12062692 FMO1 171245579 G 0.69 .0009 0.14 0.97 .7002 0.48
1 rs7539057 FMO1 171248614 A 0.70 .0012 0.14 0.95 .4840 0.42
1 rs742350 FMO1 171250044 T 0.69 .0012 0.14 1.03 .6911 0.46
1 rs12091482 FMO1 171251509 T 0.70 .0012 0.14 0.94 .4723 0.42
1 rs10399952 FMO1 171251663 G 0.69 .0011 0.14 0.95 .5037 0.42
1 rs10399602 FMO1 171251876 C 0.70 .0012 0.14 0.95 .4840 0.42
1 rs7519999 FMO1 171251958 G 0.70 .0012 0.14 0.95 .4840 0.42
1 rs1126692 FMO1 171252287 G 0.70 .0012 0.14 0.93 .3914 0.46
1 rs12092985 FMO1 171252537 A 0.70 .0012 0.14 0.95 .4840 0.42
1 rs10912714 FMO1 171253037 G 0.69 .0011 0.14 0.95 .4840 0.42
1 rs12059179 FMO1 171255346 T 0.70 .0012 0.14 0.91 .2620 0.39
Significant	findings	were	given	in	bold.
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decided	 by	 Bonferroni	 correction	 and	 thus	were	 different	 for	 each	
dataset.	We	utilized	.008	(.05/6)	and	.0025	(.05/20)	as	p-	value	thresh-











































common	 variants	 in	 FMO1,	 FMO3,	 and	 FMO6P	 through	 large-	scale	
targeted	sequencing.
A	number	of	common	variants	in	FMO1	were	identified	to	be	sig-
nificantly	 associated	with	 nicotine	 dependence,	 and	we	 noted	 that	
there	was	an	ethnic-	specific	pattern.	We	identified	a	cluster	of	signif-
icant	variants	in	FMO1	 in	the	European	Americans.	The	most	signifi-
cant	variant	was	rs6674596	(p = .0004,	OR = 0.67,	MAF_EA = 0.135,).	
However,	 this	 significant	 result	 was	 not	 replicated	 in	 our	 African	
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Several	 significant	 SNPs	 reported	 in	 that	 study,	 including	 rs742350	
and	 rs1126692,	were	 also	 identified	 to	 be	 significant	 in	 our	 study.	
Considering	both	studies	utilized	COGEN	samples,	our	results	on	the	
common	SNPs	basically	replicated	Hinrichs’	results.	In	addition	to	the	
significant	findings	 in	European	American	 sample	 set,	we	also	 iden-
tified	 a	 set	 of	 significant	variants	 located	on	gene	FMO6P	 from	 the	
African	American	dataset	(with	the	most	significant	SNP	rs6608453,	
p = .001,	 MAF_AA = 0.097).	 Just	 like	 significant	 variants	 were	 only	
identified	 in	 European	 Americans,	 this	 significant	 signal	 of	 FMO6P 
was	only	identified	in	African	Americans,	but	failed	to	be	replicated	in	















The	most	 significant	 rare	 variant	 set	was	 identified	 for	 gene	FMO1 
with	 region	 definition	 of	 “gene	 region”	 and	 MAF	<	0.01	 in	 African	
Americans	(p = .0636).	The	lack	of	significant	findings	for	rare	variants	















properly	expressed	as	a	protein,	and	 it	 is	probably	because	 it	 is	un-
able	to	produce	a	full-	length	transcript	(Hines	et	al.,	2002).	FMO6P	is	
reported	 to	 have	 significant	 sequence	 homology	with	FMO3	 (Hines	
et	al.,	 2002).	 Previous	 studies	 have	 set	 up	 direct	 links	 of	 SNPs	 in	





















there	are	also	 some	 limitations	 to	 this	 study	 that	need	 to	be	noted.	
First,	we	lack	replication	for	our	significant	findings.	The	design	using	
two	 racial/ethnic	 groups	 in	 our	 study	 enabled	 us	 to	 use	 as	 the	 two	
datasets	as	replication	set	for	each	other.	However,	significant	findings	
in	the	European	American	dataset	were	not	confirmed	in	the	African	





ments.	 Future	work	 to	 address	 this	 challenge	would	 be	 to	 combine	




(FMO1,	FMO3,	 and	FMO6P)	 on	 nicotine	dependence	by	 performing	
targeted	 sequencing	 on	 2,852	 nicotine-	dependent	 and	 nondepen-
dent	smokers.	We	performed	both	variant-	level	and	gene/region-	level	
analyses	 to	 examine	 the	 genetic	 association	of	 rare,	 low-	frequency,	
and	common	variants	within	 these	region	and	nicotine	dependence,	
and	both	SNVs	and	indels.	We	identified	significant	association	signals	
for	 gene	FMO1	 and	FMO6P.	 Replications	 of	 our	 finds	 in	 other	 eth-
nic	groups	were	needed	in	the	future.	Most	of	the	significant	variants	
identified	were	SNPs	located	within	intron	regions	or	with	unknown	
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